Under this transaction, Organovo will receive an upfront payment as well as milestones to be paid as FXR314 achieves key regulatory and commercial milestones. Lilly is acquiring all commercial and ...
Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...
Wednesday announced plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing ...
US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback